114 related articles for article (PubMed ID: 18485794)
21. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
22. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
Burgess JK; Boustany S; Moir LM; Weckmann M; Lau JY; Grafton K; Baraket M; Hansbro PM; Hansbro NG; Foster PS; Black JL; Oliver BG
Am J Respir Crit Care Med; 2010 Jan; 181(2):106-15. PubMed ID: 19875687
[TBL] [Abstract][Full Text] [Related]
23. [Significance of a reversal expression of the angiopoietin-1 and 2 in oral squamous cell carcinoma].
Li C; Zhang B; Wang ZH; Chen JC; Li B; Wang SX; Chen J; Li CH; Wang W; Song YF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 May; 44(5):412-8. PubMed ID: 19567053
[TBL] [Abstract][Full Text] [Related]
24. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
25. [Anti-tumor peptide of tumstatin in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice].
Wang C; Li Q; Yao H; Liu M; Xiao Y; Jin D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 26(6):277-9. PubMed ID: 22675939
[TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
28. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma.
Gao Q; Tong W; Luria JS; Wang Z; Nussenbaum B; Krebsbach PH
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):266-71. PubMed ID: 20074910
[TBL] [Abstract][Full Text] [Related]
29. A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle.
Thevenard J; Ramont L; Mir LM; Dupont-Deshorgue A; Maquart FX; Monboisse JC; Brassart-Pasco S
Biochem Biophys Res Commun; 2013 Mar; 432(4):549-52. PubMed ID: 23454380
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin.
Gu Q; Sun C; Luo J; Zhang T; Wang L
Anticancer Drugs; 2014 Oct; 25(9):1044-51. PubMed ID: 24942148
[TBL] [Abstract][Full Text] [Related]
31. Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.
Masui M; Okui T; Shimo T; Takabatake K; Fukazawa T; Matsumoto K; Kurio N; Ibaragi S; Naomoto Y; Nagatsuka H; Sasaki A
Anticancer Res; 2016 Jun; 36(6):2775-81. PubMed ID: 27272788
[TBL] [Abstract][Full Text] [Related]
32. Effects of eukaryotic expression plasmid encoding human tumstatin gene on endothelial cells in vitro.
Yang YP; Xu CX; Hou GS; Xin JX; Wang W; Liu XX
Chin Med J (Engl); 2010 Aug; 123(16):2269-73. PubMed ID: 20819678
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
Sudhakar A; Boosani CS
Pharm Res; 2008 Dec; 25(12):2731-9. PubMed ID: 18551250
[TBL] [Abstract][Full Text] [Related]
34. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
35. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
36. [The cloning and expression of angiogenic inhibitor tumstatin(45-132) in E. coli].
Luo YQ; Wang LH; Qiu Y; Jiao BH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):141-3. PubMed ID: 15766393
[TBL] [Abstract][Full Text] [Related]
37. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
[TBL] [Abstract][Full Text] [Related]
38. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.
Yigitbasi OG; Younes MN; Doan D; Jasser SA; Schiff BA; Bucana CD; Bekele BN; Fidler IJ; Myers JN
Cancer Res; 2004 Nov; 64(21):7977-84. PubMed ID: 15520205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
